Detalhe da pesquisa
1.
Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
AIDS Care
; 30(12): 1502-1506, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991274
2.
Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
BMC Infect Dis
; 17(1): 466, 2017 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676076
3.
Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
BMC Infect Dis
; 17(Suppl 1): 706, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143625
4.
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.
Lancet HIV
; 11(6): e380-e388, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740027
5.
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
J Med Virol
; 81(10): 1691-701, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19697403
6.
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
Lancet HIV
; 6(11): e750-e759, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601544
7.
Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.
AIDS Res Hum Retroviruses
; 34(6): 477-480, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575909
8.
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.
PLoS One
; 12(11): e0186686, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117238
9.
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Lancet HIV
; 4(9): e384-e392, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566227
10.
Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study.
Pan Afr Med J
; 23: 105, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222692
11.
Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.
AIDS Res Hum Retroviruses
; 32(12): 1159-1162, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342228
12.
Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of the West African Database to evaluate AIDS collaboration.
J Int AIDS Soc
; 17: 19064, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128907
13.
The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.
J Int AIDS Soc
; 17: 18646, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24433983
14.
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
PLoS One
; 8(6): e66135, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824279
15.
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso.
J Acquir Immune Defic Syndr
; 49(1): 17-25, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18667925